GlobeNewswire Inc.··NaGalectin's Belapectin Shows Promise in Advanced MASH Cirrhosis at EASL 2026
Galectin Therapeutics' belapectin shows statistically significant reduction in varices development in advanced MASH cirrhosis, earning TOP Poster at EASL 2026.
GALTliver diseasebelapectin